Starting his career with just a vision, Richard Upjohn would become known as one of the most famous church architects in the United States. Although not everyone agreed with him at first, Upjohn ...
Pfizer will be a smaller company assuming the Mylan-Upjohn transaction closes. Upjohn generated 22% of Pfizer's total revenue in the drugmaker's second quarter. Pfizer hasn't reported how much of its ...
One of the world’s largest generic drugmakers and a division of one of the largest pharmaceutical companies are combining to create a new pharmaceutical company. Pittsburgh-based Mylan and Upjohn – ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Pfizer's revenue growth will improve once the Upjohn-Mylan merger wraps up. The big drugmaker will receive a nice $12 billion cash windfall from the deal. Pfizer shareholders will still receive a ...
Even with the $12 billion additional cash from the Upjohn-Mylan deal, “I still do not see the need to do a large deal right now,” Pfizer CEO Albert Bourla said. (Pfizer) By offloading its established ...
The generics merger between Mylan and Pfizer's Upjohn unit has won European antitrust clearance after product sell-offs. (MPD01605/CC BY-SA 2.0) The proposed merger between Mylan and Pfizer’s Upjohn, ...
Upjohn v. United States, 449 U.S. 383 (1981), articulated the widely accepted standard for privilege protection in the corporate setting. But some litigants who rely on that famous case’s statement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results